Similar articles

• Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.

  Hoy J, Mijch A, Sandland M, Grayson L, Lucas R, Dwyer B. Hoy J, et al. J Infect Dis. 1990 Apr;161(4):801-5. doi: 10.1093/infdis/161.4.801. J Infect Dis. 1990. PMID: 2156947
• Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.

  Masur H, Tuazon C, Gill V, Grimes G, Baird B, Fauci AS, Lane HC. Masur H, et al. J Infect Dis. 1987 Jan;155(1):127-9. doi: 10.1093/infdis/155.1.127. J Infect Dis. 1987. PMID: 3794396 No abstract available.
• Solving the dilemma of antimycobacterial chemotherapy.

  Rastogi N, Falkinham JO 3rd. Rastogi N, et al. Res Microbiol. 1996 Jan-Feb;147(1-2):7-10. doi: 10.1016/0923-2508(96)80196-3. Res Microbiol. 1996. PMID: 8761715 Review. No abstract available.
• A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.

  Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG, Fanning MM, Tsoukas CM. Shafran SD, et al. N Engl J Med. 1996 Aug 8;335(6):377-83. doi: 10.1056/NEJM199608083350602. N Engl J Med. 1996. PMID: 8676931 Clinical Trial.
• Clinical trials in Mycobacterium avium therapy: lessons to take home.

  Dautzenberg B. Dautzenberg B. Res Microbiol. 1994 Mar-Apr;145(3):197-206. doi: 10.1016/0923-2508(94)90018-3. Res Microbiol. 1994. PMID: 7809472 Review. No abstract available.